Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation

Applied Therapeutics Inc. (APLT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2023 4 SKYLER JAY S (Director) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 20,000 shares @ $0
06/08/2023 4 MARCUS JOEL S (Director) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 20,000 shares @ $0
06/08/2023 4 Lerner Teena (Director) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 20,000 shares @ $0
06/08/2023 4 Kanter Stacy J. (Director) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 20,000 shares @ $0
06/08/2023 4 Funtleyder Leslie D. (Director) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 20,000 shares @ $0
01/13/2023 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Sold 15,870 shares @ $0.91, valued at $14.4k
Granted 1,964,362 shares @ $0
01/13/2023 4 Perfetti Riccardo (Chief Medical Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Sold 6,053 shares @ $0.91, valued at $5.5k
Granted 550,000 shares @ $0
01/13/2023 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Sold 4,495 shares @ $0.91, valued at $4.1k
Granted 300,000 shares @ $0
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/14/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Bought 50,000 shares @ $0.645, valued at $32.3k
10/13/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Bought 73,256 shares @ $0.5582, valued at $40.9k
10/12/2022 4 Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Bought 38,153 shares @ $0.5227, valued at $19.9k
09/16/2022 4 MARCUS JOEL S (Director) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Exercised 7,389 options to buy @ $1.05, valued at $7.8k
Exercised 10,230 options to buy @ $1.05, valued at $10.7k
Exercised 16,500 options to buy @ $1.05, valued at $17.3k
Exercised 4,125 options to buy @ $1.05, valued at $4.3k
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Mahadevan Chids (See Remarks) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Disposed/sold 19,058 options to buy @ $2.02, valued at $38.5k
Disposed/sold 19,058 options to buy @ $1.05, valued at $20k
Disposed/sold 7,264 options to buy @ $17.05, valued at $123.9k
Disposed/sold 7,264 options to buy @ $1.05, valued at $7.6k
Disposed/sold 8,824 options to buy @ $49.6, valued at $437.7k
Disposed/sold 8,824 options to buy @ $1.05, valued at $9.3k
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 Mahadevan Chids (See Remarks) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Sold 905 shares @ $1.65, valued at $1.5k
04/15/2022 4 Perfetti Riccardo (Chief Medical Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $2.02, valued at $101k
04/15/2022 4 Ortega Steven A. (Principal Accounting Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 3,081 shares @ $0
Granted 10,675 options to buy @ $2.02, valued at $21.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy